TY - CHAP M1 - Book, Section TI - Antifungal Agents A1 - Rogers, P. David A1 - Krysan, Damian J. A2 - Brunton, Laurence L. A2 - Hilal-Dandan, Randa A2 - Knollmann, Björn C. PY - 2017 T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e AB - AbbreviationsABC: ATP-binding cassetteABCD: amphotericin B colloidal dispersionABLC: amphotericin B lipid complexAUC: area under the CP-time curve.C-AMB: conventional amphotericin BCGD: chronic granulomatous diseaseCNS: central nervous systemCSF: cerebrospinal fluidCYP: cytochrome P450dTMP: deoxythymidine-5′-monophosphatedUMP: deoxyuridine-5′-monophosphateFDA: Food and Drug Administration5FdUMP: 5-fluoro-2′-deoxyuridine-5′-monophosphate5FU: 5-fluorouracil5FUDP: 5-fluorouridine-5′-diphosphate5FUMP: 5-fluorouracil-ribose monophosphate5FUTP: 5-fluorouridine triphosphateGVHD: graft-versus-host diseaseART: antiretroviral therapyHIV-AIDS: human immunodeficiency virus–acquired immunodeficiency syndromeL-AMB: liposomal amphotericin BPCP:Pneumocystis carinii pneumoniaPJP:Pneumocystis jiroveci pneumoniaSBECD: sulfobutyl ether β-cyclodextrinTLR: toll-like receptorUPRTase: uracil phosphoribosyl transferase SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - hemonc.mhmedical.com/content.aspx?aid=1162545602 ER -